glucagon receptor antagonism in diabetes treatment
Glucagon receptor antagonism in diabetes treatment refers to the use of medications to block the activity of glucagon receptors, which are proteins involved in regulating blood sugar levels. By inhibiting these receptors, the medications can help reduce the production of glucose by the liver, leading to better blood sugar control in individuals with diabetes.
Requires login.
Related Concepts (1)
Similar Concepts
- glucagon receptor agonists
- glucagon receptor antagonists
- glucagon receptor biology
- glucagon receptor knockout mice
- glucagon receptor knockout models
- glucagon receptor knockout studies
- glucagon receptor mutations
- glucagon receptor pharmacology
- glucagon receptor phosphorylation
- glucagon receptor signaling pathway
- glucagon receptor-mediated effects
- glucagon receptor-related diseases
- glucagon-like peptide-1 (glp-1) receptor agonists
- glucagon-like peptide-1 receptor agonists
- insulin receptor antagonist